Are endoscopists definitely stepping into the arena of weight-loss therapy?

Elisabeth M. H. Mathus-Vliegen

doi:10.1055/s-0034-1391081

Endoscopy, Table of Contents

Endoscopy 2015; 47(01): 8-10
DOI: 10.1055/s-0034-1391081

Editorial

Are endoscopists definitely stepping into the arena of weight-loss therapy?

Elisabeth M. H. Mathus-Vliegen

Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, The Netherlands

› Author Affiliations

Abstract

Full Text

References

References
1 Delgado-Aros S, Locke III GR, Camilleri M et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol 2004; 99: 1801-1806
2 Aro P, Ronkainen J, Talley NJ et al. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut 2005; 54: 1377-1383
3 Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. NEJM 2003; 348: 1625-1638
4 Renehan AG, Tyson M, Egger M et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578
5 Mathus-Vliegen EMH. The cooperation between endoscopists and surgeons in treating complications of bariatric surgery. Best Pract Res Clin Gastroenterol 2014; 28: 703-725
6 World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity, Geneva, 3 – 5 June 1997. Geneva: World Health Organization; 1998 WHO/NUT/NCD/98.1
7 National Institutes of Health, National Heart, Lung and Blood institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults – the evidence report. Obes Res 1998; 6: 1S-209S
8 National Institute for Health and Care Excellence. Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. 2006 Available from: www.NICE.org.uk/CG43 Accessed: 9 October 2014
9 Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013; 23: 427-436
10 Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg 2008; 18: 1611-1617
11 Mathus-Vliegen EM. Intragastric balloon treatment for obesity: what does it really offer?. Dig Dis 2008; 26: 40-44
12 Imaz I, Martinez-Cervell C, Garcia-Alvarez EE et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg 2008; 18: 841-846
13 Genco A, Cipriano M, Bacci V et al. BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes (Lond) 2006; 30: 129-133
14 Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 2005; 61: 19-27
15 de Jonge C, Rensen SS, Verdam FJ et al. Endoscopic duodenal–jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg 2013; 23: 1354-1360
16 Zechmeister-Koss I, Huic M, Fischer S. The duodenal–jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review. Obes Surg 2014; 24: 310-323
17 Forssell H, Norén E. Results after 6-months use of the AspireAssist system, a novel endoscopic weight loss therapy. Endoscopy 2015; 47: 68
18 Sullivan S, Stein R, Jonnalagadda S et al. Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology 2013; 145: 1245-1252
19 McGarr SE, Kirby DF. Percutaneous endoscopic gastrostomy (PEG) placement in the overweight and obese patient. J Parenter Enteral Nutr 2007; 31: 212-216
20 Mathus-Vliegen EMH. Endoscopic treatment: the past, the present and the future. Best Pract Res Clin Gastroenterol 2014; 28: 685-702